HT
NKTR icon

HAP Trading’s Nektar Therapeutics NKTR Stock Holding History

HAP Trading’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,167
Closed -$74K – 2232
2022
Q1 		$74K Buy
1,167
+394
+51% +$58.3K ﹤0.01% 1136
2021
Q4 		$37K Buy
+773
New +$168K ﹤0.01% 1596
2020
Q1 		– Sell
-693
Closed -$62K – 1412
2019
Q4 		$62K Buy
+693
New +$201K ﹤0.01% 668

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

HAP Trading's NKTR Position: Q4 2018 in Review

HAP Trading sold out of Nektar Therapeutics (NKTR) in Q4 2018, closing a stake of 7,914 shares — an estimated $4.78M sold.

HAP Trading first reported a position in NKTR in Q2 2018 and held it in 2 quarters. The position peaked at $7.24M in Q3 2018. 343 funds tracked by Wall St. Rank hold NKTR as of Q4 2018.

  • HAP Trading reported no remaining Nektar Therapeutics position as of Q4 2018 after selling out during the quarter.
  • HAP Trading sold 7,914 Nektar Therapeutics shares in Q4 2018, an estimated $4.78M.
  • HAP Trading first reported a position in Nektar Therapeutics in Q2 2018 and held it in 2 quarters.
  • HAP Trading's Nektar Therapeutics position peaked at $7.24M in Q3 2018.
  • 343 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2018.

Based on HAP Trading's 13F filing for Q4 2018, filed 12 Feb 2019.